This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakamura, Y. Articles by Bucala, R. Search for Related Content PubMed PubMed Citation Articles by Nakamura, Y. Articles by Bucala, R.

American Journal of Pathology, Vol 143, 1649-1656, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus

Y Nakamura, Y Horii, T Nishino, H Shiiki, Y Sakaguchi, T Kagoshima, K Dohi, Z Makita, H Vlassara and R Bucala
First Department of Internal Medicine, Nara Medical University, Japan.

Advanced glycosylation end products (AGEs) accumulate on long-lived extracellular matrix proteins and have been implicated in the micro- and macrovascular complications of diabetes mellitus. Within the arterial wall, AGE-modified proteins increase vascular permeability, inactivate nitric oxide activity, and induce the release of growth- promoting cytokines. Recently developed anti-AGE antibodies were used in an immunohistochemical analysis of coronary arteries obtained from type II diabetic and nondiabetic patients. High levels of AGE reactivity were observed within the atherosclerotic plaque present in vessels from selected patients with diabetes. Considered together with the pathological effects of AGEs on vascular wall homeostasis, these data support the role of advanced glycosylation in the rapidly progressive atherosclerosis associated with diabetes mellitus.

This article has been cited by other articles:

				J. Dilley, A. Ganesan, R. Deepa, M. Deepa, G. Sharada, O. D. Williams, and V. Mohan Association of A1C With Cardiovascular Disease and Metabolic Syndrome in Asian Indians With Normal Glucose Tolerance Diabetes Care, June 1, 2007; 30(6): 1527 - 1532. [Abstract] [Full Text] [PDF]

				A. Lapolla, F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Baccarin, B. Laverda, and D. Fedele Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease Diabetes Care, March 1, 2007; 30(3): 670 - 676. [Abstract] [Full Text] [PDF]

				A. Baidoshvili, P.A.J. Krijnen, K. Kupreishvili, C. Ciurana, W. Bleeker, R. Nijmeijer, C.A. Visser, F.C. Visser, C.J.L.M. Meijer, W. Stooker, et al. N{epsilon}-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2497 - 2503. [Abstract] [Full Text] [PDF]

				T. DeVries-Seimon, Y. Li, P. M. Yao, E. Stone, Y. Wang, R. J. Davis, R. Flavell, and I. Tabas Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor J. Cell Biol., October 10, 2005; 171(1): 61 - 73. [Abstract] [Full Text] [PDF]

				M. F. LOPES-VIRELLA, S. R. THORPE, M B. DERRICK, C. CHASSEREAU, and G. VIRELLA The Immunogenicity of Modified Lipoproteins Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 367 - 378. [Abstract] [Full Text] [PDF]

				C. Falcone, E. Emanuele, A. D'Angelo, M. P. Buzzi, C. Belvito, M. Cuccia, and D. Geroldi Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1032 - 1037. [Abstract] [Full Text] [PDF]

				G. Virella, M. B. Derrick, V. Pate, C. Chassereau, S. R. Thorpe, and M. F. Lopes-Virella Development of Capture Assays for Different Modifications of Human Low-Density Lipoprotein Clin. Vaccine Immunol., January 1, 2005; 12(1): 68 - 75. [Abstract] [Full Text] [PDF]

				G. Virella, S. R. Thorpe, N. L. Alderson, M. B. Derrick, C. Chassereau, J. M. Rhett, and M. F. Lopes-Virella Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies J. Lipid Res., October 1, 2004; 45(10): 1859 - 1867. [Abstract] [Full Text] [PDF]

				G. Basta, A. M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res, September 1, 2004; 63(4): 582 - 592. [Abstract] [Full Text] [PDF]

				B. E. Suys, N. Katier, R. P.A. Rooman, D. Matthys, L. Op De Beeck, M. V.L. Du Caju, and D. De Wolf Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy Diabetes Care, August 1, 2004; 27(8): 1947 - 1953. [Abstract] [Full Text] [PDF]

				F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance JAMA, April 21, 2004; 291(15): 1857 - 1863. [Abstract] [Full Text] [PDF]

				A. Kabat, K. Ponicke, A. Salameh, F.-W. Mohr, and S. Dhein Effect of a {beta}2-Adrenoceptor Stimulation on Hyperglycemia-Induced Endothelial Dysfunction J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 564 - 573. [Abstract] [Full Text] [PDF]

				M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara Adverse Effects of Dietary Glycotoxins on Wound Healing in Genetically Diabetic Mice Diabetes, November 1, 2003; 52(11): 2805 - 2813. [Abstract] [Full Text] [PDF]

				R. D. G. Leslie, H. Beyan, P. Sawtell, B. O. Boehm, T. D. Spector, and H. Snieder Level of an Advanced Glycated End Product Is Genetically Determined: A Study of Normal Twins Diabetes, September 1, 2003; 52(9): 2441 - 2444. [Abstract] [Full Text] [PDF]

				G. Virella and M. F. Lopes-Virella Lipoprotein Autoantibodies: Measurement and Significance Clin. Vaccine Immunol., July 1, 2003; 10(4): 499 - 505. [Full Text] [PDF]

				Y. Tamura, H. Adachi, J.-i. Osuga, K. Ohashi, N. Yahagi, M. Sekiya, H. Okazaki, S. Tomita, Y. Iizuka, H. Shimano, et al. FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products J. Biol. Chem., April 4, 2003; 278(15): 12613 - 12617. [Abstract] [Full Text] [PDF]

				G. Virella, S. R. Thorpe, N. L. Alderson, E. M. Stephan, D. Atchley, F. Wagner, and M. F. Lopes-Virella Autoimmune response to advanced glycosylation end-products of human LDL J. Lipid Res., March 1, 2003; 44(3): 487 - 493. [Abstract] [Full Text] [PDF]

				M. A. Glomb and C. Pfahler Amides Are Novel Protein Modifications Formed by Physiological Sugars J. Biol. Chem., November 2, 2001; 276(45): 41638 - 41647. [Abstract] [Full Text] [PDF]

				M. Kanauchi, N. Tsujimoto, and T. Hashimoto Advanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease Diabetes Care, September 1, 2001; 24(9): 1620 - 1623. [Abstract] [Full Text] [PDF]

				L. Dow and S. Ebrahim Commentary: Lung function and risk of fatal and non-fatal stroke--The Copenhagen City Heart Study Int. J. Epidemiol., February 1, 2001; 30(1): 152 - 153. [Full Text] [PDF]

				P. R. Moreno, A. M. Murcia, I. F. Palacios, M. N. Leon, V. H. Bernardi, V. Fuster, and J. T. Fallon Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus Circulation, October 31, 2000; 102(18): 2180 - 2184. [Abstract] [Full Text] [PDF]

				H. M Crauwels, A. G Herman, and H. Bult Local application of advanced glycation end products and intimal hyperplasia in the rabbit collared carotid artery Cardiovasc Res, July 1, 2000; 47(1): 173 - 182. [Abstract] [Full Text] [PDF]

				S. Dhein, S. Hochreuther, C. a. d. Spring, K. Bollig, C. Hufnagel, and M. Raschack Long-Term Effects of the EndothelinA Receptor Antagonist LU 135252 and the Angiotensin-Converting Enzyme Inhibitor Trandolapril on Diabetic Angiopathy and Nephropathy in a Chronic Type I Diabetes Mellitus Rat Model J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 351 - 359. [Abstract] [Full Text]

				Y. Al-Abed, T. Mitsuhashi, H. Li, J. A. Lawson, G. A. FitzGerald, H. Founds, T. Donnelly, A. Cerami, P. Ulrich, and R. Bucala Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol PNAS, March 2, 1999; 96(5): 2385 - 2390. [Abstract] [Full Text] [PDF]

				N. Sasaki, R. Fukatsu, K. Tsuzuki, Y. Hayashi, T. Yoshida, N. Fujii, T. Koike, I. Wakayama, R. Yanagihara, R. Garruto, et al. Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases Am. J. Pathol., October 1, 1998; 153(4): 1149 - 1155. [Abstract] [Full Text] [PDF]

				J.-L. Wautier and P.-J. Guillausseau Diabetes, advanced glycation endproducts and vascular disease Vascular Medicine, May 1, 1998; 3(2): 131 - 137. [Abstract] [PDF]

				H. Sano, T. Higashi, K. Matsumoto, J. Melkko, Y. Jinnouchi, K. Ikeda, Y. Ebina, H. Makino, B. Smedsrod, and S. Horiuchi Insulin Enhances Macrophage Scavenger Receptor-mediated Endocytic Uptake of Advanced Glycation End Products J. Biol. Chem., April 10, 1998; 273(15): 8630 - 8637. [Abstract] [Full Text] [PDF]

				A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc Res, March 1, 1998; 37(3): 586 - 600. [Abstract] [Full Text] [PDF]

				P. Reaven, S. Merat, F. Casanada, M. Sutphin, and W. Palinski Effect of Streptozotocin-Induced Hyperglycemia on Lipid Profiles, Formation of Advanced Glycation Endproducts in Lesions, and Extent of Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2250 - 2256. [Abstract] [Full Text]

				L. E. Wagenknecht, R. D'Agostino Jr, P. J. Savage, D. H. O'Leary, M. F. Saad, and S. M. Haffner Duration of Diabetes and Carotid Wall Thickness : The Insulin Resistance Atherosclerosis Study (IRAS) Stroke, May 1, 1997; 28(5): 999 - 1005. [Abstract] [Full Text]

				S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes J. Biol. Chem., February 14, 1997; 272(7): 4037 - 4042. [Abstract] [Full Text] [PDF]

				R. H. Nagaraj, I. N. Shipanova, and F. M. Faust Protein Cross-linking by the Maillard Reaction. ISOLATION, CHARACTERIZATION, AND IN VIVO DETECTION OF A LYSINE-LYSINE CROSS-LINK DERIVED FROM METHYLGLYOXAL J. Biol. Chem., August 9, 1996; 271(32): 19338 - 19345. [Abstract] [Full Text] [PDF]

				Y. Al-Abed, H. Liebich, W. Voelter, and R. Bucala Hydroxyalkenal Formation Induced by Advanced Glycosylation of Low Density Lipoprotein J. Biol. Chem., February 9, 1996; 271(6): 2892 - 2896. [Abstract] [Full Text] [PDF]

				C. M. Beard, R. J. Barnard, D. C. Robbins, J. M. Ordovas, and E. J. Schaefer Effects of Diet and Exercise on Qualitative and Quantitative Measures of LDL and Its Susceptibility to Oxidation Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 201 - 207. [Abstract] [Full Text]

				J. A. Silva, A. Escobar, T. J. Collins, S. R. Ramee, and C. J. White Unstable Angina : A Comparison of Angioscopic Findings Between Diabetic and Nondiabetic Patients Circulation, October 1, 1995; 92(7): 1731 - 1736. [Abstract] [Full Text]

				W. Palinski, T. Koschinsky, S. W. Butler, E. Miller, H. Vlassara, A. Cerami, and J. L. Witztum Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 571 - 582. [Abstract] [Full Text]

				N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products J. Biol. Chem., January 26, 2001; 276(5): 3195 - 3202. [Abstract] [Full Text] [PDF]

				N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products J. Biol. Chem., April 13, 2001; 276(16): 13348 - 13355. [Abstract] [Full Text] [PDF]